17-Hydroxysteroid Dehydrogenases
"17-Hydroxysteroid Dehydrogenases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of enzymes that catalyzes the oxidation of 17-hydroxysteroids to 17-ketosteroids. EC 1.1.-.
| Descriptor ID |
D015067
|
| MeSH Number(s) |
D08.811.682.047.436.375
|
| Concept/Terms |
17-Hydroxysteroid Dehydrogenases- 17-Hydroxysteroid Dehydrogenases
- 17 Hydroxysteroid Dehydrogenases
- Dehydrogenases, 17-Hydroxysteroid
- 17-Ketosteroid Reductases
- 17 Ketosteroid Reductases
- Reductases, 17-Ketosteroid
|
Below are MeSH descriptors whose meaning is more general than "17-Hydroxysteroid Dehydrogenases".
Below are MeSH descriptors whose meaning is more specific than "17-Hydroxysteroid Dehydrogenases".
This graph shows the total number of publications written about "17-Hydroxysteroid Dehydrogenases" by people in this website by year, and whether "17-Hydroxysteroid Dehydrogenases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 1 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "17-Hydroxysteroid Dehydrogenases" by people in Profiles.
-
Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women. Breast Cancer Res. 2009; 11(4):R51.
-
Genetic variation in hormone metabolizing genes and risk of testicular germ cell tumors. Cancer Causes Control. 2008 Nov; 19(9):917-29.
-
The association of genetic polymorphisms in sex hormone biosynthesis and action with insulin sensitivity and diabetes mellitus in women at midlife. Am J Med. 2006 Sep; 119(9 Suppl 1):S69-78.
-
Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies. Cancer Res. 2006 Feb 15; 66(4):2468-75.
-
Genetic variation in the HSD17B1 gene and risk of prostate cancer. PLoS Genet. 2005 Nov; 1(5):e68.
-
Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates. Cancer Res. 2001 Jan 15; 61(2):785-9.